Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Zhonghua Wei Chang Wai Ke Za Zhi ; 23(6): 589-596, 2020 Jun 25.
Artigo em Chinês | MEDLINE | ID: mdl-32521980

RESUMO

Objective: To systematically evaluate the safety and efficacy of laparoscopic versus open surgery for palliative resection of the primary tumor in stage IV colorectal cancer. Methods: The databases of CNKI, Wanfang, VIP, PubMed, EMBASE and Cochrane Library were searched to retrieve randomized controlled trials (RCT) or clinical controlled trials (CCT) comparing laparoscopic surgery with open surgery for palliative resection of the primary tumor in stage IV colorectal cancer published from January 1991 to May 2019. Chinese search terms included "colorectum/colon/rectum" , "cancer/malignant tumor" , "laparoscopy" , "metastasis" , " IV" ; English search terms included "laparoscop*" , "colo*" , "rect*" , "cancer/tumor/carcinoma/neoplasm" , " IV" , "metasta*" . Inclusion criteria: (1) RCT or CCT, with or without allocation concealment or blinding; (2) patients with stage IV colorectal cancer that was diagnosed preoperatively and would receive resection of the primary tumor; (3) the primary tumor that was palliatively resected by laparoscopic or open procedure. Exclusion criteria: (1) no valid data available in the literature; (2) single study sample size ≤20; (3) subjects with colorectal benign disease; (4) metastatic resection or lymph node dissection was performed intraoperatively in an attempt to perform radical surgery; (5) duplicate publication of the literature. Two researchers independently evaluated the quality of the included studies. In case of disagreement, the evaluation was performed by discussion or a third researcher was invited to participate. The data were extracted from the included studies, and the Cochrane Collaboration RevMan 5.1.0 version software was used for this meta-analysis. Results: Four CCTs with a total of 864 patients were included in this study, including 216 patients in the laparoscopic group and 648 patients in the open group. Compared with the open group, except for longer operation time (WMD=37.60, 95% CI: 26.11 to 49.08, P<0.05), laparoscopic group had less intraoperative blood loss (WMD=-74.89, 95% CI: -144.78 to -5.00, P<0.05), earlier first flatus and food intake after surgery (WMD=-1.00, 95% CI: -1.12 to -0.87, P<0.05; WMD=-1.61, 95%CI: -2.16 to -1.06, P<0.05), shorter hospital stay (WMD=-2.01, 95% CI: -2.21 to -1.80, P<0.05) and lower morbidity of postoperative complication (OR=0.52, 95% CI: 0.35 to 0.77, P<0.05). However, no significant differences were found in time to start postoperative chemotherapy, postoperative chemotherapy rate, and mortality (P > all 0.05). Conclusion: Laparoscopic surgery for palliative resection of the primary tumor is safe and feasible to enhance recovery after surgery by promoting postoperative bowel function recovery, shortening hospital stay and reducing postoperative complication in stage IV colorectal cancer.


Assuntos
Neoplasias Colorretais/cirurgia , Procedimentos Cirúrgicos do Sistema Digestório/métodos , Cuidados Paliativos/métodos , Colectomia/métodos , Humanos , Laparoscopia , Laparotomia , Protectomia/métodos , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento
2.
Exp Clin Immunogenet ; 10(1): 45-9, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8398201

RESUMO

A water-soluble component extracted from Salvia miltiorrhiza Bge has been used for many years in traditional Chinese medicine ('huo xie hua yu') for the treatment of the hyperviscosity syndrome. We demonstrate here that this extract promotes macrophage proliferation in vitro and enhances macrophage synthesis of the C4 component of complement. No increase in synthesis of other complement components by macrophages was observed. In a group of 20 patients with the hyperviscosity syndrome treated with an aqueous extract of Salvia, serum levels of C4 rose significantly over the course of treatment (mean pretreatment level 37.4 mg%, mean posttreatment level, 43.5 mg%; p < 0.01). The rise in C4 levels closely correlated with the disappearance of the patients' clinical symptoms.


Assuntos
Complemento C4/biossíntese , Medicamentos de Ervas Chinesas/farmacologia , Macrófagos/efeitos dos fármacos , Viscosidade Sanguínea/efeitos dos fármacos , Contagem de Células/efeitos dos fármacos , Proteínas do Sistema Complemento/efeitos dos fármacos , Proteínas do Sistema Complemento/metabolismo , Ensaio de Imunoadsorção Enzimática , Humanos , Macrófagos/metabolismo , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...